Tegaserod-induced myocardial infarction: case report and hypothesis.
about
Cellular mechanisms underlying the laxative effect of flavonol naringenin on rat constipation modelTegaserod for constipation-predominant irritable bowel syndrome.Prucalopride-associated acute tubular necrosis.Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersBloating and functional gastro-intestinal disorders: where are we and where are we going?Aqueous extracts of Liriope platyphylla induced significant laxative effects on loperamide-induced constipation of SD rats.Tegaserod mimics the neurostimulatory glycan polysialic acid and promotes nervous system repair.Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.Diagnosis and treatment of chronic constipation--a European perspective.Prokinetics in the Management of Functional Gastrointestinal Disorders.Current pharmacological treatment of gastroparesis.Review of tegaserod in the treatment of irritable bowel syndrome.Uridine stimulate laxative effect in the loperamide-induced constipation of SD rats through regulation of the mAChRs signaling pathway and mucin secretion.The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome.Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic reviewPharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.New Options in Constipation Management.Gastroparesis in children.Tegaserod-induced myocardial infarction: case report and hypothesis--an alternative viewpoint.Effect of buspirone, a 5-HT1A receptor agonist, on esophageal motility in healthy volunteers.Balancing drug risk and benefit: toward refining the process of FDA decisions affecting patient care.Colonic N-methyl-d-aspartate receptor contributes to visceral hypersensitivity in irritable bowel syndrome.
P2860
Q28473690-BCF9446C-76F6-4F4D-A922-3ED4B7EA781EQ33436477-EC42966D-C6C0-4A41-9935-BD37B4733E65Q34047629-834BA9A0-C9F7-4C2B-BC46-4716FD110C57Q34166903-A150F420-044C-4C15-B9EA-6C783EADC076Q34366956-E81D4E58-C50D-43C1-957E-BD7BE4730F42Q34464917-E6AEA454-8F5A-4244-9A6B-F6E84F93861EQ34997967-E80FD473-73C2-4EB6-B558-4034B2277DBAQ35059682-917DB865-52C1-4F16-BC3B-4155A447DA21Q35207439-AD01669C-6F19-4712-AAC7-6720DD3B1390Q35834499-DDCE98C2-C536-405C-8E4F-A35DE03AEB6FQ35925503-28212591-D03D-4D32-8126-2741B754FF25Q35925555-1618E2C4-968C-455A-9C4B-250F77F5C9D7Q36260077-DFADFC19-8AEC-4E31-AD76-7599C4DA6C7DQ36407290-64D90EAF-24ED-4F2E-9A72-A192CADDE0ABQ37051409-E826C67A-C4C2-42E2-99E7-3C945E9852D3Q37954521-C861F793-FF76-47C6-A7F4-313D4032ECBEQ38602701-A4A21EC0-FAD7-4805-99C8-03B27148A009Q42406640-1496C8BF-E10D-433E-BBA4-DAB2439E0453Q45146736-D297C0E8-1BF2-4525-9EDC-E560A0C788C3Q45446715-CD293D37-92F8-4219-8B51-A25424C3E64EQ46657336-9D8E2646-ABA2-4B4B-A708-0E7E33FC6AB4Q48542382-06DD2A3C-EA39-4733-BE48-AA66D39D8080
P2860
Tegaserod-induced myocardial infarction: case report and hypothesis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Tegaserod-induced myocardial infarction: case report and hypothesis.
@ast
Tegaserod-induced myocardial infarction: case report and hypothesis.
@en
type
label
Tegaserod-induced myocardial infarction: case report and hypothesis.
@ast
Tegaserod-induced myocardial infarction: case report and hypothesis.
@en
prefLabel
Tegaserod-induced myocardial infarction: case report and hypothesis.
@ast
Tegaserod-induced myocardial infarction: case report and hypothesis.
@en
P2093
P2860
P1433
P1476
Tegaserod-induced myocardial infarction: case report and hypothesis.
@en
P2093
Anthony J Busti
Byron Cryer
Jose R Murillo
P2860
P304
P356
10.1592/PHCO.24.5.526.33351
P407
P577
2004-04-01T00:00:00Z